{"id":"https://openalex.org/W2884786148","doi":"https://doi.org/10.1007/s12325-018-0748-3","title":"Comparison of Characteristics of Benign Prostatic Hyperplasia (BPH) Patients Treated with Finasteride and Alpha Blocker Combination Therapy Versus Alpha Blocker Monotherapy in China: An Analysis of Electronic Medical Record Data","display_name":"Comparison of Characteristics of Benign Prostatic Hyperplasia (BPH) Patients Treated with Finasteride and Alpha Blocker Combination Therapy Versus Alpha Blocker Monotherapy in China: An Analysis of Electronic Medical Record Data","publication_year":2018,"publication_date":"2018-07-16","ids":{"openalex":"https://openalex.org/W2884786148","doi":"https://doi.org/10.1007/s12325-018-0748-3","mag":"2884786148","pmid":"https://pubmed.ncbi.nlm.nih.gov/30014350"},"language":"en","primary_location":{"id":"doi:10.1007/s12325-018-0748-3","doi":"https://doi.org/10.1007/s12325-018-0748-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12325-018-0748-3","pdf_url":null,"source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101866735","display_name":"Yanyan Fu","orcid":"https://orcid.org/0000-0002-9103-9175","observed_orcids":["https://orcid.org/0000-0002-9103-9175"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanyan Fu","raw_affiliation_strings":["Medical Affairs Department, Merck Sharp and Dohme (China), Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs Department, Merck Sharp and Dohme (China), Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Simeng Han","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simeng Han","raw_affiliation_strings":["Analysis Group, Inc, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100335838","display_name":"Li Wang","orcid":"https://orcid.org/0000-0001-6944-1195","observed_orcids":["https://orcid.org/0000-0001-6944-1195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Wang","raw_affiliation_strings":["Medical Affairs Department, Merck Sharp and Dohme (China), Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs Department, Merck Sharp and Dohme (China), Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103149851","display_name":"Wei Gao","orcid":"https://orcid.org/0000-0002-4088-3210","observed_orcids":["https://orcid.org/0000-0002-4088-3210"]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Gao","raw_affiliation_strings":["Analysis Group, Inc, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc, Boston, MA, USA","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089194015","display_name":"Eric Qiong Wu","orcid":"https://orcid.org/0000-0001-8379-3373","observed_orcids":["https://orcid.org/0000-0001-8379-3373"]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Wu","raw_affiliation_strings":["Analysis Group, Inc, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc, Boston, MA, USA","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100422535","display_name":"Xian Cao","orcid":"https://orcid.org/0000-0003-2544-4954","observed_orcids":["https://orcid.org/0000-0003-2544-4954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xian Cao","raw_affiliation_strings":["Medical Affairs Department, Merck Sharp and Dohme (China), Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs Department, Merck Sharp and Dohme (China), Beijing, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073657241","display_name":"Jianye Wang","orcid":"https://orcid.org/0000-0001-7173-566X","observed_orcids":["https://orcid.org/0000-0001-7173-566X"]},"institutions":[{"id":"https://openalex.org/I4210119648","display_name":"Beijing Hospital","ror":"https://ror.org/02jwb5s28","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210119648"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jianye Wang","raw_affiliation_strings":["Department of Urology, Beijing Hospital, National Center of Gerontology, Beijing, China. wangjy@bjhmoh.cn","Department of Urology, Beijing Hospital, National Center of Gerontology, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Beijing Hospital, National Center of Gerontology, Beijing, China. wangjy@bjhmoh.cn","institution_ids":["https://openalex.org/I4210119648"]},{"raw_affiliation_string":"Department of Urology, Beijing Hospital, National Center of Gerontology, Beijing, China","institution_ids":["https://openalex.org/I4210119648"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5073657241"],"corresponding_institution_ids":["https://openalex.org/I4210119648"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":0.8382,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.72603724,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"35","issue":"8","first_page":"1191","last_page":"1198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benign-prostatic-hyperplasia","display_name":"benign prostatic hyperplasia","score":1.0},{"id":"https://openalex.org/keywords/finasteride","display_name":"finasteride","score":0.9990000128746033},{"id":"https://openalex.org/keywords/alpha-blockers","display_name":"alpha-blockers","score":0.8059999942779541},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9129999876022339},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/5alpha-reductase-inhibitors","display_name":"5-alpha reductase inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/comorbidity-burden","display_name":"comorbidity burden","score":0.8109999895095825},{"id":"https://openalex.org/keywords/charlson-comorbidity-index","display_name":"Charlson Comorbidity Index","score":0.9049999713897705},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.5260000228881836},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.9679999947547913},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.9589999914169312},{"id":"https://openalex.org/keywords/patient-characteristics","display_name":"patient characteristics","score":0.5370000004768372},{"id":"https://openalex.org/keywords/china","display_name":"China","score":0.6840000152587891},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.8410000205039978},{"id":"https://openalex.org/keywords/practice-patterns","display_name":"clinical practice patterns","score":0.6399999856948853},{"id":"https://openalex.org/keywords/age-at-treatment-initiation","display_name":"age at treatment initiation","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9308251142501831},{"id":"https://openalex.org/C2775874879","wikidata":"https://www.wikidata.org/wiki/Q424167","display_name":"Finasteride","level":4,"score":0.8802269697189331},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.6471146941184998},{"id":"https://openalex.org/C2994510025","wikidata":"https://www.wikidata.org/wiki/Q179661","display_name":"Medical therapy","level":2,"score":0.4828386902809143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4754961431026459},{"id":"https://openalex.org/C2778742482","wikidata":"https://www.wikidata.org/wiki/Q816759","display_name":"Beta blocker","level":3,"score":0.4593063294887543},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.439665824174881},{"id":"https://openalex.org/C2777562237","wikidata":"https://www.wikidata.org/wiki/Q835051","display_name":"Hyperplasia","level":2,"score":0.4137316048145294},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4101814329624176},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.18244457244873047},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.12130862474441528},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.09472456574440002},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.05360543727874756},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002681","descriptor_name":"China","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018120","descriptor_name":"Finasteride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D057286","descriptor_name":"Electronic Health Records","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058891","descriptor_name":"5-alpha Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s12325-018-0748-3","doi":"https://doi.org/10.1007/s12325-018-0748-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12325-018-0748-3","pdf_url":null,"source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},{"id":"pmid:30014350","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30014350","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1987068717","https://openalex.org/W2039680542","https://openalex.org/W2040416376","https://openalex.org/W2061326496","https://openalex.org/W2088880077","https://openalex.org/W2105669626","https://openalex.org/W2121759271","https://openalex.org/W2217135291","https://openalex.org/W2412588600","https://openalex.org/W2590330230","https://openalex.org/W2598826369","https://openalex.org/W2742843570"],"related_works":["https://openalex.org/W2007002471","https://openalex.org/W2524035794","https://openalex.org/W2767132566","https://openalex.org/W7095440683","https://openalex.org/W183865857","https://openalex.org/W2075704489","https://openalex.org/W2892884827","https://openalex.org/W2005710212","https://openalex.org/W2130782215","https://openalex.org/W2025164066"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-08-03T00:00:00"}